eISSN: 2345-6558

Free Access

Journal of Parathyroid Disease 2018;6(1):19-22 doi: 10.15171/jpd.2018.07
Therapeutic impact of cholecalciferol in patients with psychiatric disorders receiving olanzapine

Original

Somayeh Kaviyani 1 * , Mohammad Bahadoram 2, Gholamreza Houshmand 3, Samaneh Bahadoram 2

1 Department of Psychiatry, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2 Medical Student Research Committee, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
3 Department of Pharmacology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran


*Corresponding author: Somayeh Kaviyani,
Email: Kaviyani.s@ajums.ac.ir


Abstract

Introduction: Psychiatric disorders such as schizophrenia require appropriate treatment. Second-generation antipsychotics, including olanzapine, are administered as an appropriated treatment for these disorders. However, this drug has several complications, such as obesity and increased waist circumference which reduces the acceptance of the treatment.

Objectives: The aim of this study was to investigate the effects of vitamin D3 therapy on waist circumference caused by olanzapine. Patients and Methods: In this randomized clinical trial, 50 hospitalized women with psychiatric disorders receiving olanzapine were divided into two groups of intervention and control groups. Before the intervention, the waist circumference, hip circumference, and waist-hip ratio were measured. Then, for 12 weeks, the intervention group received vitamin D3 and the control group received paraffin as the placebo, one pearl every 2 weeks. Waist circumference, hip circumference, and waist-hip ratio were re-measured and the collected data were analyzed by pair t test.

Results: Our findings showed that there is a significant decrease in waist circumference and waist-hip ratio in intervention group (P<0.001). However, these changes were not significant in the placebo group. Hip circumference was not changed significantly in both groups.

Conclusion: Vitamin D can be administered concomitant with 0lanzapine to improve side effects of olanzapine such as increasing waist circumference.



Notes

Please cite this paper as: Kaviyani S, Bahadoram M, Houshmand G, Bahadoram S. Therapeutic impact of cholecalciferol in patients with psychiatric disorders receiving olanzapine. J Parathyr Dis. 2018;6(1):19-22. DOI: 10.15171/jpd.2018.07

Copyright © 2018 The Author(s); Published by Nickan Research Institute. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Comments
First name  
Last name  
Email address  
Comments  
Security code



Article
PDF


Export citation
EndNote
Reference Manager
BibTeX
Medlars
Refworks

Cite by
Google Scholar

Google Scholar
Articles by Somayeh Kaviyani
Articles by Mohammad Bahadoram
Articles by Gholamreza Houshmand
Articles by Samaneh Bahadoram
Similar articles
Related articles

PubMed
Articles by Somayeh Kaviyani
Articles by Mohammad Bahadoram
Articles by Gholamreza Houshmand
Articles by Samaneh Bahadoram


Article Access Statistics
Viewed
PDF Downloaded
Comments

Share this article!
Creative Commons Attribution 4.0 License This work is licensed under a Creative Commons Attribution 4.0 License.
Copyright © 2016 The Author(s)
Published by Nickan Research Institute